Continuous dopaminergic stimulation reduces risk of motor complications in parkinsonian primates
- 31 March 2005
- journal article
- Published by Elsevier BV in Experimental Neurology
- Vol. 192 (1), 73-78
- https://doi.org/10.1016/j.expneurol.2004.11.013
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Striatal plasticity and extrapyramidal motor dysfunctionParkinsonism & Related Disorders, 2004
- A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson’s diseaseExperimental Neurology, 2003
- Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian modelsNeurology, 2001
- Pathophysiology of levodopa-induced dyskinesia: Potential for new therapiesNature Reviews Neuroscience, 2001
- Frequency of levodopa‐related dyskinesias and motor fluctuations as estimated from the cumulative literatureMovement Disorders, 2001
- Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonismTrends in Neurosciences, 2000
- Sustained Cabergoline Treatment Reverses Levodopa-Induced Dyskinesias in Parkinsonian MonkeysClinical Neuropharmacology, 2000
- Intranasal Apomorphine Rescue Therapy for Parkinsonian “Off” PeriodsClinical Neuropharmacology, 1996
- Wearing‐off fluctuations in Parkinson's disease: Contribution of postsynaptic mechanismsAnnals of Neurology, 1994
- Continuous lisuride effects on central dopaminergic mechanisms in Parkinson's diseaseAnnals of Neurology, 1992